Digital health management for preventing ischemic stroke recurrence

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and evaluate a WeChat-based intelligent management system designed for the secondary prevention of ischemic stroke and transient ischemic attack. Participants will be randomly assigned to receive either standard care or the digital management system, which integrates patient data with mobile IoT devices for self-monitoring. The system provides personalized feedback on risk factor control and facilitates communication between patients and healthcare providers. Follow-up assessments will occur at one year to evaluate clinical outcomes and medication adherence.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 18 years.
2. Patients diagnosed with acute ischemic stroke or transient ischemic attack.
3. Time from onset to enrollment ≤ 14 days.
4. Presence of at least one modifiable risk factor (hypertension, diabetes).
5. Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
6. Signed informed consent by the patient or their family members.

Exclusion Criteria:

1. Patients already enrolled in other stroke-related healthcare quality improvement projects or clinical trials.
2. Patients or family members who refuse to sign the informed consent form.
3. Pregnant or breastfeeding women.

Where it's running

• Beijing Tiantan Hospital
  Beijing, China Recruiting
• Beijing Tsinghua Changgung Hospital
  Beijing, Beijing Municipality, China Active not recruiting
• The First Affiliated Hospital of Shihezi University
  Shihezi, Xinjiang, China Active not recruiting

Study contacts

• Study coordinator: Zhiyuan Feng, MD
• Email: fzyhhz1996@gmail.com
• Phone: 86+15801290121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy

  This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.

  Recruiting at 24 sites Phase 3 Hanyang University · Busan, Busan and 23 other locations · NCT07687706

• Same-day ambulatory stroke unit care for older adults with minor stroke or TIA

  This trial will try whether same-day ambulatory stroke unit care works as well as inpatient stroke unit care for people aged 60 and older with minor ischemic stroke, transient ischemic attack, or retinal ischemia.

  Recruiting University Hospital Heidelberg · Heidelberg · NCT07420374

• Intelligent lipid-management system to help stroke or TIA patients on evolocumab reach one-year LDL-C targets

  We will test whether an intelligent lipid-management decision-support system helps adults in China with ischemic stroke or TIA who are taking evolocumab reach LDL-C under 1.8 mmol/L after one year.

  Recruiting Beijing Tiantan Hospital · Beijing · NCT07143149

• Registry of stroke cases in Brest

  This study is collecting information on stroke cases in Brest to see how common strokes are, understand their impact on patients, and find better ways to treat them.

  Recruiting University Hospital, Brest · Brest · NCT02900521

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Remote ischemic conditioning for post-stroke insomnia

  A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.

  Recruiting Sichuan Academy of Medical Sciences · Chengdu, Sichuan · NCT07874594

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.